AMELUZ (Biofrontera Inc.)
Welcome to the PulseAid listing for the AMELUZ drug offered from Biofrontera Inc.. This Porphyrin Precursor [EPC],Porphyrinogens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Biofrontera Inc. |
NON-PROPRIETARY NAME: | aminolevulinic acid hydrochloride |
SUBSTANCE NAME: | AMINOLEVULINIC ACID HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Porphyrin Precursor [EPC],Porphyrinogens [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-08-26 |
END MARKETING DATE: | 0000-00-00 |
AMELUZ HUMAN PRESCRIPTION DRUG Details:
Item Description | AMELUZ from Biofrontera Inc. |
LABELER NAME: | Biofrontera Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/g) |
START MARKETING DATE: | 2016-08-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70621-101_06c09242-ddf3-4ea2-b2e2-e7a6ca753df3 |
PRODUCT NDC: | 70621-101 |
APPLICATION NUMBER: | NDA208081 |
Other AMINOLEVULINIC ACID HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: